Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group
about
Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancerIrinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for advanced and/or metastatic colorectal cancerIrinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for advanced and/or metastatic colorectal cancerChronomodulated chemotherapy versus conventional chemotherapy for Advanced and /or Metastatic Colorectal CancerSurgical resection of hepatic metastases from colorectal cancer: a systematic review of published studiesOral versus intravenous fluoropyrimidines for metastatic colorectal cancerResection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomesTreatment of colorectal cancer in the elderlyInflammation-based factors and prognosis in patients with colorectal cancerManagement of locally advanced and metastatic colon cancer in elderly patientsThe role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancerHigh-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volumeReviews of individual patient data (IPD) are useful for geriatrics: an overview of available IPD reviews.Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.Palliative excisional surgery for primary colorectal cancer in patients with incurable metastatic disease. Is there a survival benefit? A systematic review.Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancerResponse of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy.S-1-based therapy versus 5-FU-based therapy in advanced gastric cancer: a meta-analysis.Patients' preferences for participation in treatment decision-making at the end of life: qualitative interviews with advanced cancer patients.Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasisOutcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.Chemotherapy for advanced color. Please aim for accuracy rather than hard hitting headlines.The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG).Pharmacogenetics of irinotecan: An ethnicity-based prediction of irinotecan adverse events.Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care.Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablationImprovements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992-2008.Patients' perspectives on palliative chemotherapy of colorectal and non--colorectal cancer: a prospective study in a chemotherapy- experienced populationWhich endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer?Metastatic colorectal cancer: systemic treatment in the new millennium.The efficacy and safety of adding bevacizumab to cetuximab- or panitumumab-based therapy in the treatment of patients with metastatic colorectal cancer (mCRC): a meta-analysis from randomized control trials.Health-related quality of life in colorectal cancer patients.Haemoglobin A1c--a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS).Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases.Quality of life and colorectal cancer: a review.Follow-up after colorectal cancer surgery.Tegafur-uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle.Bax expression is a candidate prognostic and predictive marker of colorectal cancer.Adjuvant therapies for colorectal cancer.
P2860
Q24186145-88D83315-8E47-4940-A0A7-A721FC32823EQ24200737-421EDB05-2E64-4035-A03E-05E4ADA8D857Q24234555-FE32D80C-803F-47E6-9F2B-1F1DD0348DEBQ24239845-5FD439A2-4D27-48CB-9763-EF7744732443Q24651894-BD65E817-D0F5-460C-8E7E-633BFBF8558EQ26472148-7BB41F30-061A-412D-A0B1-78C4094686B7Q26750691-46BF2816-2423-4093-A0E4-4D5B8FF402C9Q26781457-3120B86A-BB59-480E-BE11-404A52540A2DQ26797425-CE0280F0-1895-4CA5-9ACD-7DFC747800ADQ27026129-719979E9-CF20-41CD-A76C-ED83D9790607Q28304399-12275B5B-DE95-4E85-A56F-56DACBADF934Q30448575-6A28F84C-696F-46E2-BAC5-5422B112A8D4Q30815345-4615BD4B-5DED-49A0-BF08-C5E694F69CE7Q31016826-29E2F02B-7520-45A4-8B17-3B2270FA4009Q31030358-D22202FA-1D70-4980-B94E-8237A6A6FA8DQ33414068-90F90AA3-D2E7-4A56-B173-7134B0A7A363Q33477125-C1DF6288-DB7B-4F19-92F4-31A13CF0A84BQ33605846-8713A5F6-AD69-4FDB-9EDF-E08F6001BAE6Q33806752-0C71E2C9-409C-470C-BCA0-08830A95BAEDQ33914190-9FE87DCA-D46D-4487-BD7A-43099370A175Q34050151-74EB1CB7-54B7-4E3A-8A7C-0E4FF5587137Q34131641-07168A09-722B-43D3-AF18-88D5452E30A7Q34334152-09C2D048-ADCE-4D0A-AB4B-C6559287D261Q34391234-13D383AC-7BF4-4C01-85B9-28DBAD2C39CEQ34449797-060BBDDF-14FF-4C3B-B496-9BF4178505A6Q34482350-EB3684D2-DD85-44A2-9AE9-AA342298228CQ34579685-4CE5351E-D7DE-411E-895C-BE6547DEDDEEQ34580422-6829A020-C1CE-4E6F-AA5A-1623DE557A99Q34711507-52086516-115E-4C18-8647-1E12E5C0AF8EQ35148795-1A598BC1-FEC0-4005-8A3E-959532A34968Q35173455-D1DC7615-E07E-4902-AE47-B5A9804E1825Q35204956-422F3952-B7EF-4AAD-BFE2-FD6A9A9EC271Q35576082-EF1BCBA8-31DC-4610-833C-66A392D8A7FEQ35580945-31BDF689-69C9-430C-9B6D-5226624C6DE7Q35595559-EF87A124-9022-48A7-B429-0297F0CD137FQ35620278-C02D7252-067F-4336-8D58-BC5BABBA1F7FQ35669537-F8FF59F9-C71F-4DBD-8DEA-535E4A673B85Q36061168-521F1114-86C8-4873-8865-2C4CC5BB6B4DQ36097096-168FFB4E-E47A-4DFE-A4D2-CBEA596F5D62Q36177963-F9BC85DA-1F2D-4FAC-A185-DB9FD0541BE0
P2860
Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Palliative chemotherapy for ad ...... tal Cancer Collaborative Group
@ast
Palliative chemotherapy for ad ...... tal Cancer Collaborative Group
@en
Palliative chemotherapy for ad ...... tal Cancer Collaborative Group
@nl
type
label
Palliative chemotherapy for ad ...... tal Cancer Collaborative Group
@ast
Palliative chemotherapy for ad ...... tal Cancer Collaborative Group
@en
Palliative chemotherapy for ad ...... tal Cancer Collaborative Group
@nl
prefLabel
Palliative chemotherapy for ad ...... tal Cancer Collaborative Group
@ast
Palliative chemotherapy for ad ...... tal Cancer Collaborative Group
@en
Palliative chemotherapy for ad ...... tal Cancer Collaborative Group
@nl
P2860
P921
P356
P1433
P1476
Palliative chemotherapy for ad ...... tal Cancer Collaborative Group
@en
P2093
P C Simmonds
P2860
P304
P356
10.1136/BMJ.321.7260.531
P407
P577
2000-09-01T00:00:00Z